DataVXSmallPaper
journal article·2023-06Open access

Oncolytic Virus‐Driven Biotherapies from Bench to Bedside (Small 23/2023)

Shijie Duan, Shuhang Wang, Lei Qiao, Xinbo Yu, Nan Wang, Liting Chen, Xinyuan Zhang, Xu Zhao, Hongyu Liu, Tianye Wang, Ying Wu, Ning Li, Funan Liu

Small· Volume 19· Issue 23
Publisher pageOpen full text
Source abstract

Abstract

Oncolytic Virotherapies In article number 2206948, Ying Wu, Ning Li, Funan Liu, and co-workers provide a more advanced approach to cancer immunotherapy, i.e. the oncolytic virotherapy. Oncolytic viruses selectively replicate in tumor cells and exert antitumor effects through direct oncolysis and inducting immune responses, where tumor antigens from the lysing cells enhance antitumor immunity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Virus-based gene therapy research · Cancer Research and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Surgical Oncology and General Surgery The First Hospital of China Medical University Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors China Medical University Ministry of Education Phase I Clinical Trials Center The First Hospital of China Medical University Shenyang 110001 China

Clinical Trial Center National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China

Colorectal and Henia Minimally Invasive Surgery Unit Department of General Surgery Shengjing Hospital of China Medical University Shenyang 110004 China

Phase I Clinical Trials Center The First Hospital of China Medical University Department of General Practice The First Hospital of China Medical University Shenyang 110001 China

References

Reference metadata was not supplied for this record.